Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Vaccines

  Free Subscription


Articles published in Indian Pediatr

Retrieve available abstracts of 16 articles:
HTML format
Text format



Single Articles


    February 2019
  1. KUMAR CM, Bedi N
    Tuberculin Conversion after BCG Vaccination.
    Indian Pediatr. 2019;56:141-142.
    PubMed     Text format    


    January 2019
  2. THAKRE R, Patil PS
    Influenza Vaccine Paradox.
    Indian Pediatr. 2019;56:80.
    PubMed     Text format    


    December 2018
  3. BALASUBRAMANIAN S, Shah A, Pemde HK, Chatterjee P, et al
    Indian Academy of Pediatrics (IAP) Advisory Committee on Vaccines and Immunization Practices (ACVIP) Recommended Immunization Schedule (2018-19) and Update on Immunization for Children Aged 0 Through 18 Years.
    Indian Pediatr. 2018;55:1066-1074.
    PubMed     Text format     Abstract available


  4. JAVADEKAR B, Ghosh A, Kompithra RZ, Awasthi S, et al
    Safety and Immunogenicity of Two Doses of a Quadrivalent Meningococcal Polysaccharide Diphtheria Toxoid Conjugate Vaccine in Indian and Russian Children Aged 9 to 17 Months.
    Indian Pediatr. 2018;55:1050-1055.
    PubMed     Text format     Abstract available


    November 2018
  5. SHET A, O'Brien KL
    Non-vaccine Serotypes of Streptococcus Pneumoniae: Readying India for Monitoring Pneumococcal Conjugate Vaccine Use.
    Indian Pediatr. 2018;55:947-949.
    PubMed     Text format    


    October 2018
  6. JOHN J, Varghese R, Lionell J, Neeravi A, et al
    Non-vaccine Pneumococcal Serotypes Among Children with Invasive Pneumococcal Disease.
    Indian Pediatr. 2018;55:874-876.
    PubMed     Text format     Abstract available


    May 2018
  7. DUTTA AK
    Hepatitis B Vaccination Strategies Using Combination Vaccines for Low Birthweight Infants.
    Indian Pediatr. 2018;55:379-380.
    PubMed     Text format    


    February 2018
  8. HANSASHREE P, Verma S, Rawat A, Sankhyan N, et al
    Long-term Seroprotection Rates Following One-dose Measles (9-month) and One-dose MMR Vaccination (15 months) in Indian Children.
    Indian Pediatr. 2018 Feb 9. pii: S097475591600116.
    PubMed     Text format     Abstract available


    January 2018
  9. SAFFAR H, Khalilian AR, Saffar MJ, Ajami A, et al
    Long-term Protection Against the Hepatitis B Virus Detected Through an Early Response to a Booster Dose Injection.
    Indian Pediatr. 2018;55:45-47.
    PubMed     Text format     Abstract available


    December 2017
  10. RAMACHANDRAN VG
    Campaign Mode MMR Vaccination to Control Outbreak of Mumps in a Highly Vaccinated Population: Virologist's viewpoint.
    Indian Pediatr. 2017;54:1050-1051.
    PubMed     Text format    


  11. VASHISHTHA VM
    Campaign Mode MMR Vaccination to Control Outbreak of Mumps in a Highly Vaccinated Population: Pediatrician's Viewpoint.
    Indian Pediatr. 2017;54:1049-1050.
    PubMed     Text format    


  12. MATHEW JL
    Campaign Mode MMR Vaccination to Control Outbreak of Mumps in a Highly Vaccinated Population: Evidence-based Medicine viewpoint.
    Indian Pediatr. 2017;54:1047-1049.
    PubMed     Text format    


  13. SHAH N, Parikh R, Casabona G, Kolhapure S, et al
    A New Combined Vaccine Against Measles, Mumps, Rubella and Varicella in India.
    Indian Pediatr. 2017;54:1041-1046.
    PubMed     Text format     Abstract available


  14. DEWAN P, Gupta P
    Hepatitis B Vaccination Strategy in HIV-infected Children.
    Indian Pediatr. 2017;54:1001-1003.
    PubMed     Text format    


    August 2017
  15. RAJMA J, Arun AC
    Severe Complications of Mumps.
    Indian Pediatr. 2017;54:689.
    PubMed     Text format    


    April 2017
  16. SACHDEVA A
    An Appeal to all Pediatricians and Members of Indian Academy of Pediatrics for the Measles-Rubella Campaign.
    Indian Pediatr. 2017;54:269-270.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Vaccines is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: